Strategy
MSTR
MARA Holdings
MARA
Petroleo Brasileiro SA Petrobras
PBR
4
Adobe
ADBE
5
Vale SA
VALE
US Stock MarketDetailed Quotes
ATHA Athira
- 0.335
- +0.017+5.44%
Close Mar 14 16:00 ET
- 0.340
- +0.004+1.28%
Post 17:55 ET
13.09MMarket Cap-0.13P/E (TTM)
0.340High0.317Low118.79KVolume0.318Open0.318Pre Close39.00KTurnover0.43%Turnover RatioLossP/E (Static)39.04MShares3.67052wk High0.29P/B9.24MFloat Cap0.30152wk Low--Dividend TTM27.56MShs Float34.790Historical High--Div YieldTTM7.17%Amplitude0.301Historical Low0.328Avg Price1Lot Size
About Athira Company
Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.
Company Profile
SymbolATHA
Company NameAthira
Listing DateSep 18, 2020
Issue Price17.00
Founded2011
CEODr. Mark J. Litton, PhD
MarketNASDAQ
Employees26
Fiscal Year Ends12-31
Address18706 North Creek Parkway,Suite 104
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98011
Phone1-425-620-8501
Websitehttp://www.athira.com
Company Executives
- Name
- Position
- Salary
- Dr. Mark J. Litton, PhD
- Director, President and Chief Executive Officer
- 2.26M
- Dr. Kevin Church, PhD
- Chief Scientific Officer
- --
- Robert Renninger
- Principal Financial Officer, Principal Accounting Officer and Vice President, Finance
- --
- Barbara Kosacz, J.D.
- Independent Director
- 102.39K
- James A. Johnson
- Independent Director
- 106.87K
- Grant E. Pickering
- Independent Director
- 96.53K
- Joseph Edelman
- Independent Director
- 92.77K
- John M. Fluke, Jr
- Independent Director
- 95.89K
- Dr. Michael A. Panzara, M.D.
- Independent Director
- 89.36K
- Mark Worthington
- General Counsel and Corporate Secretary
- --
- Kelly A. Romano
- Chairwoman of the Board
- 124.68K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!